SHARON MCLEMORE: Open Payments
NPI 1750616801 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 17 payments from 8 companies in 2025. Trend: 2023 $64 · 2024 $57 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $178 |
| Corcept Therapeutics | 4 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: GEMTESA, Korlym, CAPLYTA, INSPIRE, Qelbree, Ozempic, XYOSTED.
Industry payments across TX — which companies pay providers there.
